Guselkumab Approved for PsA
FDA Approves Secukinumab for Non-Radiographic Axial Spondyloarthritis
Study Compares Ixekizumab with Ustekinumab for the Treatment of Nail Psoriasis
Ixekizumab May Improve Pain & Sexual Health in Patients with Genital Psoriasis
FDA Approves Canakinumab for Adult-Onset Still’s Disease
Interleukin 17 Inhibitors Promising in Ankylosing Spondylitis Patients
Biologic Treatment Recommendations for Rheumatic Disease Patients Who Contract COVID-19
ABX464 in Phase 2a Trials for RA
Researchers Give Update on Janus Kinase (JAK) Inhibitors
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 21
- Next Page »